Genome-wide  ||| S:0 E:12 ||| JJ
analysis  ||| S:12 E:21 ||| NN
of  ||| S:21 E:24 ||| IN
alternative  ||| S:24 E:36 ||| JJ
splicing  ||| S:36 E:45 ||| NN
in  ||| S:45 E:48 ||| IN
cow ||| S:48 E:51 ||| NN
:  ||| S:51 E:53 ||| :
implications  ||| S:53 E:66 ||| NNS
in  ||| S:66 E:69 ||| IN
bovine  ||| S:69 E:76 ||| NN
as  ||| S:76 E:79 ||| IN
a  ||| S:79 E:81 ||| DT
model  ||| S:81 E:87 ||| NN
for  ||| S:87 E:91 ||| IN
human  ||| S:91 E:97 ||| JJ
diseases  ||| S:97 E:106 ||| NNS
Alternative  ||| S:106 E:118 ||| JJ
splicing  ||| S:118 E:127 ||| NNS
( ||| S:127 E:128 ||| -LRB-
AS ||| S:128 E:130 ||| NNP
)  ||| S:130 E:132 ||| -RRB-
is  ||| S:132 E:135 ||| VBZ
a  ||| S:135 E:137 ||| DT
primary  ||| S:137 E:145 ||| JJ
mechanism  ||| S:145 E:155 ||| NN
of  ||| S:155 E:158 ||| IN
functional  ||| S:158 E:169 ||| JJ
regulation  ||| S:169 E:180 ||| NN
in  ||| S:180 E:183 ||| IN
the  ||| S:183 E:187 ||| DT
human  ||| S:187 E:193 ||| JJ
genome ||| S:193 E:199 ||| NN
,  ||| S:199 E:201 ||| ,
with  ||| S:201 E:206 ||| IN
60 ||| S:206 E:208 ||| CD
%  ||| S:208 E:210 ||| NN
to  ||| S:210 E:213 ||| TO
80 ||| S:213 E:215 ||| CD
%  ||| S:215 E:217 ||| NN
of  ||| S:217 E:220 ||| IN
human  ||| S:220 E:226 ||| JJ
genes  ||| S:226 E:232 ||| NNS
being  ||| S:232 E:238 ||| VBG
alternatively  ||| S:238 E:252 ||| JJ
spliced ||| S:252 E:259 ||| NN
.  ||| S:259 E:261 ||| .
As  ||| S:261 E:264 ||| IN
part  ||| S:264 E:269 ||| NN
of  ||| S:269 E:272 ||| IN
the  ||| S:272 E:276 ||| DT
bovine  ||| S:276 E:283 ||| JJ
genome  ||| S:283 E:290 ||| JJ
annotation  ||| S:290 E:301 ||| JJ
team ||| S:301 E:305 ||| NN
,  ||| S:305 E:307 ||| ,
we  ||| S:307 E:310 ||| PRP
have  ||| S:310 E:315 ||| VBP
analysed  ||| S:315 E:324 ||| RB
4567  ||| S:324 E:329 ||| CD
bovine  ||| S:329 E:336 ||| NN
AS  ||| S:336 E:339 ||| IN
genes ||| S:339 E:344 ||| NNS
,  ||| S:344 E:346 ||| ,
compared  ||| S:346 E:355 ||| VBN
to  ||| S:355 E:358 ||| TO
16715  ||| S:358 E:364 ||| CD
human  ||| S:364 E:370 ||| JJ
and  ||| S:370 E:374 ||| CC
16491  ||| S:374 E:380 ||| CD
mouse  ||| S:380 E:386 ||| NN
AS  ||| S:386 E:389 ||| IN
genes ||| S:389 E:394 ||| NNS
,  ||| S:394 E:396 ||| ,
along  ||| S:396 E:402 ||| RB
with  ||| S:402 E:407 ||| IN
Gene  ||| S:407 E:412 ||| NNP
Ontology  ||| S:412 E:421 ||| NNP
( ||| S:421 E:422 ||| -LRB-
GO ||| S:422 E:424 ||| NNP
)  ||| S:424 E:426 ||| -RRB-
analysis ||| S:426 E:434 ||| NN
.  ||| S:434 E:436 ||| .
We  ||| S:436 E:439 ||| PRP
also  ||| S:439 E:444 ||| RB
analysed  ||| S:444 E:453 ||| VB
the  ||| S:453 E:457 ||| DT
two  ||| S:457 E:461 ||| CD
most  ||| S:461 E:466 ||| RBS
important  ||| S:466 E:476 ||| JJ
events ||| S:476 E:482 ||| NNS
,  ||| S:482 E:484 ||| ,
cassette  ||| S:484 E:493 ||| JJ
exons  ||| S:493 E:499 ||| NN
and  ||| S:499 E:503 ||| CC
intron  ||| S:503 E:510 ||| JJ
retention  ||| S:510 E:520 ||| NN
in  ||| S:520 E:523 ||| IN
94  ||| S:523 E:526 ||| CD
human  ||| S:526 E:532 ||| JJ
disease  ||| S:532 E:540 ||| NN
genes  ||| S:540 E:546 ||| NNS
and  ||| S:546 E:550 ||| CC
mapped  ||| S:550 E:557 ||| VBD
them  ||| S:557 E:562 ||| PRP
to  ||| S:562 E:565 ||| TO
the  ||| S:565 E:569 ||| DT
bovine  ||| S:569 E:576 ||| JJ
orthologous  ||| S:576 E:588 ||| JJ
genes ||| S:588 E:593 ||| NNS
.  ||| S:593 E:595 ||| .
Of  ||| S:595 E:598 ||| IN
the  ||| S:598 E:602 ||| DT
94  ||| S:602 E:605 ||| CD
human  ||| S:605 E:611 ||| JJ
inherited  ||| S:611 E:621 ||| JJ
disease  ||| S:621 E:629 ||| NN
genes ||| S:629 E:634 ||| NNS
,  ||| S:634 E:636 ||| ,
a  ||| S:636 E:638 ||| DT
protein  ||| S:638 E:646 ||| NN
domain  ||| S:646 E:653 ||| NN
analysis  ||| S:653 E:662 ||| NN
was  ||| S:662 E:666 ||| VBD
carried  ||| S:666 E:674 ||| VBN
out  ||| S:674 E:678 ||| RP
for  ||| S:678 E:682 ||| IN
the  ||| S:682 E:686 ||| DT
transcript  ||| S:686 E:697 ||| NN
sequences  ||| S:697 E:707 ||| NN
of  ||| S:707 E:710 ||| IN
12  ||| S:710 E:713 ||| CD
human  ||| S:713 E:719 ||| JJ
genes  ||| S:719 E:725 ||| NNS
that  ||| S:725 E:730 ||| WDT
have  ||| S:730 E:735 ||| VBP
orthologous  ||| S:735 E:747 ||| JJ
genes  ||| S:747 E:753 ||| NNS
and  ||| S:753 E:757 ||| CC
have  ||| S:757 E:762 ||| VBP
been  ||| S:762 E:767 ||| VBN
characterised  ||| S:767 E:781 ||| VBN
in  ||| S:781 E:784 ||| IN
cow ||| S:784 E:787 ||| NN
.  ||| S:787 E:789 ||| .
Of  ||| S:789 E:792 ||| IN
the  ||| S:792 E:796 ||| DT
21,755  ||| S:796 E:803 ||| JJ
bovine  ||| S:803 E:810 ||| JJ
genes ||| S:810 E:815 ||| NNS
,  ||| S:815 E:817 ||| ,
4,567  ||| S:817 E:823 ||| CD
genes  ||| S:823 E:829 ||| NNS
( ||| S:829 E:830 ||| -LRB-
21 ||| S:830 E:832 ||| CD
% ||| S:832 E:833 ||| NN
)  ||| S:833 E:835 ||| -RRB-
are  ||| S:835 E:839 ||| VBP
alternatively  ||| S:839 E:853 ||| RB
spliced ||| S:853 E:860 ||| JJ
,  ||| S:860 E:862 ||| ,
compared  ||| S:862 E:871 ||| VBN
to  ||| S:871 E:874 ||| TO
16,715  ||| S:874 E:881 ||| CD
( ||| S:881 E:882 ||| -LRB-
68 ||| S:882 E:884 ||| CD
% ||| S:884 E:885 ||| NN
)  ||| S:885 E:887 ||| -RRB-
in  ||| S:887 E:890 ||| IN
human  ||| S:890 E:896 ||| JJ
and  ||| S:896 E:900 ||| CC
16,491  ||| S:900 E:907 ||| NNP
( ||| S:907 E:908 ||| -LRB-
57 ||| S:908 E:910 ||| CD
% ||| S:910 E:911 ||| NN
)  ||| S:911 E:913 ||| -RRB-
in  ||| S:913 E:916 ||| IN
mouse ||| S:916 E:921 ||| NN
.  ||| S:921 E:923 ||| .
Gene-level  ||| S:923 E:934 ||| JJ
analysis  ||| S:934 E:943 ||| NN
of  ||| S:943 E:946 ||| IN
the  ||| S:946 E:950 ||| DT
orthologous  ||| S:950 E:962 ||| NN
set  ||| S:962 E:966 ||| VBD
suggested  ||| S:966 E:976 ||| VBN
that  ||| S:976 E:981 ||| IN
bovine  ||| S:981 E:988 ||| JJ
genes  ||| S:988 E:994 ||| NNS
show  ||| S:994 E:999 ||| VBP
fewer  ||| S:999 E:1005 ||| JJR
AS  ||| S:1005 E:1008 ||| IN
events  ||| S:1008 E:1015 ||| NNS
compared  ||| S:1015 E:1024 ||| VBN
to  ||| S:1024 E:1027 ||| TO
human  ||| S:1027 E:1033 ||| JJ
and  ||| S:1033 E:1037 ||| CC
mouse  ||| S:1037 E:1043 ||| NN
genes ||| S:1043 E:1048 ||| NNS
.  ||| S:1048 E:1050 ||| .
A  ||| S:1050 E:1052 ||| DT
detailed  ||| S:1052 E:1061 ||| JJ
examination  ||| S:1061 E:1073 ||| NN
of  ||| S:1073 E:1076 ||| IN
cassette  ||| S:1076 E:1085 ||| JJ
exons  ||| S:1085 E:1091 ||| NN
across  ||| S:1091 E:1098 ||| IN
human  ||| S:1098 E:1104 ||| JJ
and  ||| S:1104 E:1108 ||| CC
cow  ||| S:1108 E:1112 ||| NN
for  ||| S:1112 E:1116 ||| IN
94  ||| S:1116 E:1119 ||| CD
human  ||| S:1119 E:1125 ||| JJ
disease  ||| S:1125 E:1133 ||| NN
genes ||| S:1133 E:1138 ||| NNS
,  ||| S:1138 E:1140 ||| ,
suggested  ||| S:1140 E:1150 ||| VBD
that  ||| S:1150 E:1155 ||| IN
a  ||| S:1155 E:1157 ||| DT
majority  ||| S:1157 E:1166 ||| NN
of  ||| S:1166 E:1169 ||| IN
cassette  ||| S:1169 E:1178 ||| JJ
exons  ||| S:1178 E:1184 ||| NN
in  ||| S:1184 E:1187 ||| IN
human  ||| S:1187 E:1193 ||| NN
were  ||| S:1193 E:1198 ||| VBD
present  ||| S:1198 E:1206 ||| JJ
and  ||| S:1206 E:1210 ||| CC
constitutive  ||| S:1210 E:1223 ||| NN
in  ||| S:1223 E:1226 ||| IN
bovine  ||| S:1226 E:1233 ||| VBG
as  ||| S:1233 E:1236 ||| RB
opposed  ||| S:1236 E:1244 ||| VBN
to  ||| S:1244 E:1247 ||| TO
intron  ||| S:1247 E:1254 ||| VB
retention  ||| S:1254 E:1264 ||| NN
which  ||| S:1264 E:1270 ||| WDT
exhibited  ||| S:1270 E:1280 ||| VBD
50 ||| S:1280 E:1282 ||| CD
%  ||| S:1282 E:1284 ||| NN
of  ||| S:1284 E:1287 ||| IN
the  ||| S:1287 E:1291 ||| DT
exons  ||| S:1291 E:1297 ||| NN
as  ||| S:1297 E:1300 ||| IN
present  ||| S:1300 E:1308 ||| JJ
and  ||| S:1308 E:1312 ||| CC
50 ||| S:1312 E:1314 ||| CD
%  ||| S:1314 E:1316 ||| NN
as  ||| S:1316 E:1319 ||| IN
absent  ||| S:1319 E:1326 ||| NN
in  ||| S:1326 E:1329 ||| IN
cow ||| S:1329 E:1332 ||| NN
.  ||| S:1332 E:1334 ||| .
We  ||| S:1334 E:1337 ||| PRP
observed  ||| S:1337 E:1346 ||| VBD
that  ||| S:1346 E:1351 ||| IN
AS  ||| S:1351 E:1354 ||| NNP
plays  ||| S:1354 E:1360 ||| VBZ
a  ||| S:1360 E:1362 ||| DT
major  ||| S:1362 E:1368 ||| JJ
role  ||| S:1368 E:1373 ||| NN
in  ||| S:1373 E:1376 ||| IN
disease  ||| S:1376 E:1384 ||| NN
implications  ||| S:1384 E:1397 ||| NNS
in  ||| S:1397 E:1400 ||| IN
human  ||| S:1400 E:1406 ||| JJ
through  ||| S:1406 E:1414 ||| IN
manipulations  ||| S:1414 E:1428 ||| NNS
of  ||| S:1428 E:1431 ||| IN
essential ||| S:1431 E:1440 ||| JJ
/ ||| S:1440 E:1441 ||| FW
functional  ||| S:1441 E:1452 ||| FW
protein  ||| S:1452 E:1460 ||| FW
domains ||| S:1460 E:1467 ||| FW
.  ||| S:1467 E:1469 ||| .
It  ||| S:1469 E:1472 ||| PRP
was  ||| S:1472 E:1476 ||| VBD
also  ||| S:1476 E:1481 ||| RB
evident  ||| S:1481 E:1489 ||| JJ
that  ||| S:1489 E:1494 ||| IN
majority  ||| S:1494 E:1503 ||| NN
of  ||| S:1503 E:1506 ||| IN
these  ||| S:1506 E:1512 ||| DT
12  ||| S:1512 E:1515 ||| CD
genes  ||| S:1515 E:1521 ||| NNS
had  ||| S:1521 E:1525 ||| VBD
conservation  ||| S:1525 E:1538 ||| NN
of  ||| S:1538 E:1541 ||| IN
all  ||| S:1541 E:1545 ||| DT
essential  ||| S:1545 E:1555 ||| JJ
domains  ||| S:1555 E:1563 ||| NN
in  ||| S:1563 E:1566 ||| IN
their  ||| S:1566 E:1572 ||| PRP$
bovine  ||| S:1572 E:1579 ||| JJ
orthologous  ||| S:1579 E:1591 ||| JJ
counterpart ||| S:1591 E:1602 ||| NN
,  ||| S:1602 E:1604 ||| ,
for  ||| S:1604 E:1608 ||| IN
these  ||| S:1608 E:1614 ||| DT
human  ||| S:1614 E:1620 ||| JJ
diseases ||| S:1620 E:1628 ||| NNS
.  ||| S:1628 E:1630 ||| .
While  ||| S:1630 E:1636 ||| IN
alternative  ||| S:1636 E:1648 ||| JJ
splicing  ||| S:1648 E:1657 ||| NN
has  ||| S:1657 E:1661 ||| VBZ
the  ||| S:1661 E:1665 ||| DT
potential  ||| S:1665 E:1675 ||| JJ
to  ||| S:1675 E:1678 ||| TO
create  ||| S:1678 E:1685 ||| VB
many  ||| S:1685 E:1690 ||| JJ
mRNA  ||| S:1690 E:1695 ||| JJ
isoforms  ||| S:1695 E:1704 ||| NN
from  ||| S:1704 E:1709 ||| IN
a  ||| S:1709 E:1711 ||| DT
single  ||| S:1711 E:1718 ||| JJ
gene ||| S:1718 E:1722 ||| NN
,  ||| S:1722 E:1724 ||| ,
in  ||| S:1724 E:1727 ||| IN
cow  ||| S:1727 E:1731 ||| VBG
the  ||| S:1731 E:1735 ||| DT
majority  ||| S:1735 E:1744 ||| NN
of  ||| S:1744 E:1747 ||| IN
genes  ||| S:1747 E:1753 ||| NNS
generate  ||| S:1753 E:1762 ||| VBP
two  ||| S:1762 E:1766 ||| CD
to  ||| S:1766 E:1769 ||| TO
three  ||| S:1769 E:1775 ||| CD
isoforms ||| S:1775 E:1783 ||| NN
,  ||| S:1783 E:1785 ||| ,
compared  ||| S:1785 E:1794 ||| VBN
to  ||| S:1794 E:1797 ||| TO
six  ||| S:1797 E:1801 ||| CD
in  ||| S:1801 E:1804 ||| IN
human  ||| S:1804 E:1810 ||| JJ
and  ||| S:1810 E:1814 ||| CC
four  ||| S:1814 E:1819 ||| CD
in  ||| S:1819 E:1822 ||| IN
mouse ||| S:1822 E:1827 ||| NN
.  ||| S:1827 E:1829 ||| .
Our  ||| S:1829 E:1833 ||| PRP$
analyses  ||| S:1833 E:1842 ||| NNS
demonstrated  ||| S:1842 E:1855 ||| VBN
that  ||| S:1855 E:1860 ||| IN
a  ||| S:1860 E:1862 ||| DT
smaller  ||| S:1862 E:1870 ||| JJR
number  ||| S:1870 E:1877 ||| NN
of  ||| S:1877 E:1880 ||| IN
bovine  ||| S:1880 E:1887 ||| JJ
genes  ||| S:1887 E:1893 ||| NNS
show  ||| S:1893 E:1898 ||| VBP
greater  ||| S:1898 E:1906 ||| JJR
transcript  ||| S:1906 E:1917 ||| NN
diversity ||| S:1917 E:1926 ||| NN
.  ||| S:1926 E:1928 ||| .
GO  ||| S:1928 E:1931 ||| VB
definitions  ||| S:1931 E:1943 ||| NNS
for  ||| S:1943 E:1947 ||| IN
bovine  ||| S:1947 E:1954 ||| NN
AS  ||| S:1954 E:1957 ||| IN
genes  ||| S:1957 E:1963 ||| NNS
provided  ||| S:1963 E:1972 ||| VBD
38 ||| S:1972 E:1974 ||| CD
%  ||| S:1974 E:1976 ||| NN
more  ||| S:1976 E:1981 ||| RBR
functional  ||| S:1981 E:1992 ||| JJ
information  ||| S:1992 E:2004 ||| NN
than  ||| S:2004 E:2009 ||| IN
currently  ||| S:2009 E:2019 ||| RB
available  ||| S:2019 E:2029 ||| JJ
in  ||| S:2029 E:2032 ||| IN
the  ||| S:2032 E:2036 ||| DT
sequence  ||| S:2036 E:2045 ||| JJ
database ||| S:2045 E:2053 ||| NN
.  ||| S:2053 E:2055 ||| .
Our  ||| S:2055 E:2059 ||| PRP$
protein  ||| S:2059 E:2067 ||| NN
domain  ||| S:2067 E:2074 ||| NN
analysis  ||| S:2074 E:2083 ||| NN
helped  ||| S:2083 E:2090 ||| VBD
us  ||| S:2090 E:2093 ||| PRP
verify  ||| S:2093 E:2100 ||| VB
the  ||| S:2100 E:2104 ||| DT
suitability  ||| S:2104 E:2116 ||| NN
of  ||| S:2116 E:2119 ||| IN
using  ||| S:2119 E:2125 ||| VBG
bovine  ||| S:2125 E:2132 ||| NN
as  ||| S:2132 E:2135 ||| IN
a  ||| S:2135 E:2137 ||| DT
model  ||| S:2137 E:2143 ||| NN
for  ||| S:2143 E:2147 ||| IN
human  ||| S:2147 E:2153 ||| JJ
diseases  ||| S:2153 E:2162 ||| NNS
and  ||| S:2162 E:2166 ||| CC
also  ||| S:2166 E:2171 ||| RB
recognize  ||| S:2171 E:2181 ||| VB
the  ||| S:2181 E:2185 ||| DT
contribution  ||| S:2185 E:2198 ||| NN
of  ||| S:2198 E:2201 ||| IN
AS  ||| S:2201 E:2204 ||| NNP
towards  ||| S:2204 E:2212 ||| IN
the  ||| S:2212 E:2216 ||| DT
disease  ||| S:2216 E:2224 ||| NN
phenotypes ||| S:2224 E:2234 ||| NN
.  ||| S:2234 E:2236 ||| .
